Elie Bechara: Euronet-PHL-C1 Protocol for the Treatment of Pediatric Hodgkin Lymphoma
Elie Bechara, Clinical Instructor of Pediatrics at AUBMC, shared a post on LinkedIn:
“Happy to share our latest article. We have demonstrated the successful implementation of a risk-adapted, response-based strategy for the treatment of pediatric patients with Hodgkin Lymphoma using the Euronet-PHL-C1 protocol; which yielded excellent overall survival of 97.6%, and allowed the omission of Radiotherapy in low stage patients who achieved early response to induction therapy.”
Title: Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet‐PHL‐C1 Protocol: Experience From a Resource‐Limited Country
Authors: Elie Bechara, Toufic Eid, Arwa El-Dhuwaib, Hani Tamim, Dolly Noun, Raphah Borghol, Zaher Chakhachiro, Miguel R Abboud, Samar Muwakkit
More posts featuring Hodgkin Lymphoma on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023